News
Zacks.com on MSN13h
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. CVS Health Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback